Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment

Cancers are the leading cause of death, causing around 10 million deaths annually by 2020. The most common cancers are those affecting the breast, lungs, colon, and rectum. However, it has been noted that cancer metastasis is more lethal than just cancer incidence and accounts for more than 90% of c...

Full description

Bibliographic Details
Main Authors: Sagorika Nag, Abhimanyu Mandal, Aryaman Joshi, Neeraj Jain, Ravi Shanker Srivastava, Sanjay Singh, Arun Khattri
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Diseases
Subjects:
Online Access:https://www.mdpi.com/2079-9721/10/4/114
_version_ 1797460588261015552
author Sagorika Nag
Abhimanyu Mandal
Aryaman Joshi
Neeraj Jain
Ravi Shanker Srivastava
Sanjay Singh
Arun Khattri
author_facet Sagorika Nag
Abhimanyu Mandal
Aryaman Joshi
Neeraj Jain
Ravi Shanker Srivastava
Sanjay Singh
Arun Khattri
author_sort Sagorika Nag
collection DOAJ
description Cancers are the leading cause of death, causing around 10 million deaths annually by 2020. The most common cancers are those affecting the breast, lungs, colon, and rectum. However, it has been noted that cancer metastasis is more lethal than just cancer incidence and accounts for more than 90% of cancer deaths. Thus, early detection and prevention of cancer metastasis have the capability to save millions of lives. Finding novel biomarkers and targets for screening, determination of prognosis, targeted therapies, etc., are ways of doing so. In this review, we propose various sialyltransferases and neuraminidases as potential therapeutic targets for the treatment of the most common cancers, along with a few rare ones, on the basis of existing experimental and in silico data. This compilation of available cancer studies aiming at sialyltransferases and neuraminidases will serve as a guide for scientists and researchers working on possible targets for various cancers and will also provide data about the existing drugs which inhibit the action of these enzymes.
first_indexed 2024-03-09T17:07:12Z
format Article
id doaj.art-3ee29aaf82b940c39158da5ec57ba93c
institution Directory Open Access Journal
issn 2079-9721
language English
last_indexed 2024-03-09T17:07:12Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj.art-3ee29aaf82b940c39158da5ec57ba93c2023-11-24T14:21:46ZengMDPI AGDiseases2079-97212022-11-0110411410.3390/diseases10040114Sialyltransferases and Neuraminidases: Potential Targets for Cancer TreatmentSagorika Nag0Abhimanyu Mandal1Aryaman Joshi2Neeraj Jain3Ravi Shanker Srivastava4Sanjay Singh5Arun Khattri6Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, IndiaDepartment of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, IndiaDepartment of Chemical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, IndiaDivision of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow 226031, IndiaDepartment of Pharmacology, Career Institute of Medical Sciences & Hospital, Lucknow 226020, IndiaDepartment of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, IndiaDepartment of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, IndiaCancers are the leading cause of death, causing around 10 million deaths annually by 2020. The most common cancers are those affecting the breast, lungs, colon, and rectum. However, it has been noted that cancer metastasis is more lethal than just cancer incidence and accounts for more than 90% of cancer deaths. Thus, early detection and prevention of cancer metastasis have the capability to save millions of lives. Finding novel biomarkers and targets for screening, determination of prognosis, targeted therapies, etc., are ways of doing so. In this review, we propose various sialyltransferases and neuraminidases as potential therapeutic targets for the treatment of the most common cancers, along with a few rare ones, on the basis of existing experimental and in silico data. This compilation of available cancer studies aiming at sialyltransferases and neuraminidases will serve as a guide for scientists and researchers working on possible targets for various cancers and will also provide data about the existing drugs which inhibit the action of these enzymes.https://www.mdpi.com/2079-9721/10/4/114sialyltransferasesneuraminidasesovarian cancerbreast cancerpancreatic cancerchemoresistance
spellingShingle Sagorika Nag
Abhimanyu Mandal
Aryaman Joshi
Neeraj Jain
Ravi Shanker Srivastava
Sanjay Singh
Arun Khattri
Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
Diseases
sialyltransferases
neuraminidases
ovarian cancer
breast cancer
pancreatic cancer
chemoresistance
title Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
title_full Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
title_fullStr Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
title_full_unstemmed Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
title_short Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
title_sort sialyltransferases and neuraminidases potential targets for cancer treatment
topic sialyltransferases
neuraminidases
ovarian cancer
breast cancer
pancreatic cancer
chemoresistance
url https://www.mdpi.com/2079-9721/10/4/114
work_keys_str_mv AT sagorikanag sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT abhimanyumandal sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT aryamanjoshi sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT neerajjain sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT ravishankersrivastava sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT sanjaysingh sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment
AT arunkhattri sialyltransferasesandneuraminidasespotentialtargetsforcancertreatment